Can Dr Reddy’s Carve Into Crowded Indian Avastin Biosimilar Market?

 
• By Anju Ghangurde
  
Leadership
Dr Reddy's Launches Cut-Price Biosimilar Avastin In India • Source: Shutterstock

More from Business

More from Scrip